Diagnostics of Primary Immunodeficiencies through Next-Generation Sequencing

Background Recently, a growing number of novel genetic defects underlying primary immunodeficiencies (PIDs) have been identified, increasing the number of PID up to more than 250 well-defined forms. Next-generation sequencing (NGS) technologies and proper filtering strategies greatly contributed to this rapid evolution, providing the possibility to rapidly and simultaneously analyze large numbers of genes or the whole exome. Objective To evaluate the role of targeted NGS and whole exome sequencing (WES) in the diagnosis of a case series, characterized by complex or atypical clinical features suggesting a PID, difficult to diagnose using the current diagnostic procedures. Methods We retrospectively analyzed genetic variants identified through targeted NGS or WES in 45 patients with complex PID of unknown etiology. Results Forty-seven variants were identified using targeted NGS, while 5 were identified using WES. Newly identified genetic variants were classified into four groups: (I) variations associated with a well-defined PID, (II) variations associated with atypical features of a well-defined PID, (III) functionally relevant variations potentially involved in the immunological features, and (IV) non-diagnostic genotype, in whom the link with phenotype is missing. We reached a conclusive genetic diagnosis in 7/45 patients (~16%). Among them, four patients presented with a typical well-defined PID. In the remaining three cases, mutations were associated with unexpected clinical features, expanding the phenotypic spectrum of typical PIDs. In addition, we identified 31 variants in 10 patients with complex phenotype, individually not causative per se of the disorder. Conclusion NGS technologies represent a cost-effective and rapid first-line genetic approach for the evaluation of complex PIDs. WES, despite a moderate higher cost compared to targeted, is emerging as a valuable tool to reach in a timely manner, a PID diagnosis with a considerable potential to draw genotype–phenotype correlation. Nevertheless, a large fraction of patients still remains without a conclusive diagnosis. In these patients, the sum of non-diagnostic variants might be proven informative in future studies with larger cohorts of patients.

[1]  A. Aguzzi,et al.  Adenosine deaminase deficiency in adults. , 1997, Blood.

[2]  F. Arredondo-Vega,et al.  Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles. , 1998, American journal of human genetics.

[3]  S. Hubbard,et al.  Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course. , 1998, Pediatrics.

[4]  A. Fischer,et al.  Functional consequences of perforin gene mutations in 22 patients with familial haemophagocytic lymphohistiocytosis , 2002, British journal of haematology.

[5]  R. Clementi,et al.  Atypical features of familial hemophagocytic lymphohistiocytosis. , 2004, Blood.

[6]  J. Banchereau,et al.  Pyogenic Bacterial Infections in Humans with MyD88 Deficiency , 2003, Science.

[7]  J. B. Oliveira,et al.  Laboratory evaluation of primary immunodeficiencies. , 2010, The Journal of allergy and clinical immunology.

[8]  L. Notarangelo,et al.  Primary immunodeficiencies. , 2010, The Journal of allergy and clinical immunology.

[9]  Educational paper , 2011, European Journal of Pediatrics.

[10]  J. Shendure,et al.  Exome sequencing as a tool for Mendelian disease gene discovery , 2011, Nature Reviews Genetics.

[11]  C. Summers,et al.  A BLOC-1 mutation screen reveals that PLDN is mutated in Hermansky-Pudlak Syndrome type 9. , 2011, American journal of human genetics.

[12]  Neil A. Miller,et al.  Adopting orphans: comprehensive genetic testing of Mendelian diseases of childhood by next-generation sequencing , 2011, Expert review of molecular diagnostics.

[13]  Ivan K. Chinn,et al.  First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 cases. , 2011, Blood.

[14]  J. Casanova,et al.  Infectious Diseases in Patients with IRAK-4, MyD88, NEMO, or IκBα Deficiency , 2011, Clinical Microbiology Reviews.

[15]  Hugo Y. K. Lam,et al.  Performance comparison of exome DNA sequencing technologies , 2011, Nature Biotechnology.

[16]  C. Wijmenga,et al.  Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2. , 2011, American journal of human genetics.

[17]  E. de Vries.  Patient‐centred screening for primary immunodeficiency, a multi‐stage diagnostic protocol designed for non‐immunologists: 2011 update , 2012, Clinical and experimental immunology.

[18]  Neil A. Miller,et al.  Exome sequencing reveals a pallidin mutation in a Hermansky-Pudlak-like primary immunodeficiency syndrome. , 2012, Blood.

[19]  A. Borkhardt,et al.  Array‐Based Sequence Capture and Next‐Generation Sequencing for the Identification of Primary Immunodeficiencies , 2012, Scandinavian journal of immunology.

[20]  Peter Saffrey,et al.  Rapid Whole-Genome Sequencing for Genetic Disease Diagnosis in Neonatal Intensive Care Units , 2012, Science Translational Medicine.

[21]  Toshiro K. Ohsumi,et al.  Use of whole exome and genome sequencing in the identification of genetic causes of primary immunodeficiencies , 2012, Current opinion in allergy and clinical immunology.

[22]  V. Gallo,et al.  Severe Combined Immunodeficiences: New and Old Scenarios , 2012, International reviews of immunology.

[23]  A. Fischer,et al.  Whole-exome sequencing identifies Coronin-1A deficiency in 3 siblings with immunodeficiency and EBV-associated B-cell lymphoproliferation. , 2013, The Journal of allergy and clinical immunology.

[24]  Neil A. Miller,et al.  Combined DOCK8 and CLEC7A mutations causing immunodeficiency in 3 brothers with diarrhea, eczema, and infections. , 2013, The Journal of allergy and clinical immunology.

[25]  A. Gennery,et al.  Classification of primary immunodeficiencies: need for a revised approach? , 2013, The Journal of allergy and clinical immunology.

[26]  L. Santos‐Argumedo,et al.  Clinical and genetic analysis of patients with X‐linked hyper‐IgM syndrome , 2013, Clinical genetics.

[27]  E. Orilieri,et al.  Variations of the UNC13D Gene in Patients with Autoimmune Lymphoproliferative Syndrome , 2013, PloS one.

[28]  J. Casanova,et al.  Primary immunodeficiencies: a rapidly evolving story. , 2013, The Journal of allergy and clinical immunology.

[29]  The Natural History of Children with Severe Combined Immunodeficiency: Baseline Features of the First Fifty Patients of the Primary Immune Deficiency Treatment Consortium Prospective Study 6901 , 2013, Journal of Clinical Immunology.

[30]  J. Casanova,et al.  Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015 , 2015, Journal of Clinical Immunology.

[31]  M. Frontini,et al.  The cockayne syndrome B protein is essential for neuronal differentiation and neuritogenesis , 2014, Cell Death and Disease.

[32]  L. Moens,et al.  Diagnostics of Primary Immunodeficiency Diseases: A Sequencing Capture Approach , 2014, PloS one.

[33]  M. Shirakawa,et al.  Functional assessment of the mutational effects of human IRAK4 and MyD88 genes. , 2014, Molecular immunology.

[34]  L. Notarangelo,et al.  Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience. , 2014, The Journal of allergy and clinical immunology.

[35]  E. Cuppen,et al.  Targeted next-generation sequencing: a novel diagnostic tool for primary immunodeficiencies. , 2014, The Journal of allergy and clinical immunology.

[36]  Thomas A. Fleisher,et al.  Targeted NGS: A Cost-Effective Approach to Molecular Diagnosis of PIDs , 2014, Front. Immunol..

[37]  L. Notarangelo,et al.  Next Generation Sequencing Reveals Skewing of the T and B Cell Receptor Repertoires in Patients with Wiskott–Aldrich Syndrome , 2014, Front. Immunol..

[38]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[39]  V. Gallo,et al.  Severe combined immunodeficiency—an update , 2015, Annals of the New York Academy of Sciences.

[40]  K. M. McSweeney,et al.  Clinical application of whole-genome sequencing in patients with primary immunodeficiency. , 2015, The Journal of allergy and clinical immunology.

[41]  J. Casanova,et al.  Genetic Diagnosis Using Whole Exome Sequencing in Common Variable Immunodeficiency , 2016, Front. Immunol..

[42]  L. Dotta,et al.  Clinical heterogeneity of dominant chronic mucocutaneous candidiasis disease: presenting as treatment-resistant candidiasis and chronic lung disease. , 2016, Clinical immunology.

[43]  Carol J. Saunders,et al.  Targeted next-generation sequencing revealed MYD88 deficiency in a child with chronic yersiniosis and granulomatous lymphadenitis. , 2016, The Journal of allergy and clinical immunology.

[44]  Cristina Has,et al.  Faculty of 1000 evaluation for Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. , 2018 .

[45]  John H. Jopson,et al.  A REPORT OF TWO CASES , 1902 .